In many key markets, gaining approval by national health technology assessment (HTA) bodies is critical to commercial success of a new product launch. Typically, companies need to prepare and submit comprehensive evidence dossiers and economic models to HTA bodies, before negotiation on access conditions can begin. Successful submissions integrate clinical and economic messaging effectively, while presenting robust and transparent evidence summaries and economic models.

Our team of market access writers, health economists, systematic review and statistical analysts, and consultants are experienced in preparing for HTA submissions, with over 60 years of collective HTA experience behind them. We can hand-hold you through the process, advise on your HTA strategy and develop all you need for a robust submission.

Contact us today to find out how we can help.